Senior Medical Science Liaison Movement Disorders- South

Senior Medical Science Liaison (Sr MSL), Movement Disorders provides advanced, field-based medical and scientific leadership in support of Lundbeck’s Neuro Rare focus on multiple system atrophy. This role serves as a strategic pre-launch scientific partner to external experts and internal stakeholders, generating high-quality, actionable insights that inform evidence strategy, disease education, portfolio decision-making, and launch readiness.

The Sr MSL is expected to demonstrate outcome-oriented leadership, scientific depth, and insight generation that directly advances Neuro Rare medical strategy, strengthens external scientific credibility, and shapes the disease environment.

• Establishes and sustains deep, longitudinal scientific partnerships with Key Opinion Leaders (KOLs), Centers of Excellence, and investigators working in multiple system atrophy.
• Serves as a trusted scientific expert through high-quality, compliant scientific exchange that advances understanding of disease biology, unmet need, endpoints, and emerging evidence.
• Acts as a primary generator of pre-launch actionable field medical insights by systematically testing scientific value narratives, differentiation hypotheses, and evidence gaps through external engagement.
• Synthesizes and communicates high-quality insights with clear implications for evidence strategy, publication planning, disease education, and portfolio-level decision-making.
• Ensures timely, accurate, and compliant documentation of insights in CRM systems in alignment with defined quality standards.

• Partners closely with Medical Directors, Clinical Development, Evidence Strategy, and other cross-functional teams to align field execution with enterprise scientific priorities.
• Connects external experts internally to support advisory boards, evidence generation activities, publications, and strategic initiatives.
• Identifies and facilitates investigator-initiated trials (IITs), grant submissions, and research collaborations aligned with Neuro Rare medical strategy.
• Supports clinical development activities, including investigator identification and site outreach, as appropriate and compliant.

• Delivers impactful, non-promotional disease education that advances recognition, diagnosis, and referral pathways across Neuro Rare indications.
• Ensures consistency, scientific rigor, and alignment of disease narratives and medical lexicon across field education activities.
• Supports congress strategy execution by engaging in high-value scientific discussions, attending priority sessions, and facilitating strategic KOL interactions with Medical Leadership.
• Maintains advanced knowledge of scientific and clinical developments in Neuro Rare disease areas to inform education, insight generation, and evidence planning.

• Demonstrates scientific and behavioral leadership through role modeling of best-in-class MSL execution, engagement quality, and compliance.
• Actively contributes to Field Medical initiatives, work streams, and process improvements that enhance scalability, quality, and impact.
• Serves as a mentor and onboarding resource for new MSLs, as assigned, supporting development toward independent, high-quality field execution.
• Completes all required training, administrative responsibilities, and documentation in accordance with Lundbeck policies and regulatory requirements on time.
• Maintains full compliance with FDA, company, and governance standards with no critical findings.

• Accredited advanced degree in a health or life sciences–related field.
• ≥5 years of healthcare or related experience (industry, clinical practice, research, academic, or managed markets).
• ≥2 years of customer-facing Field Medical Affairs experience within a pharmaceutical, biotech, or life sciences organization.
• Proven experience supporting pre-launch assets, including KOL identification, strategic mapping, trial site engagement.
• Demonstrated ability to interpret complex scientific data and translate insights into meaningful scientific dialogue and…